What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 6, 2014, Pages 1474-1482

  Montes, Milagrosa ^a,b   Tamayo, Esther ^b   Mojica, Catalina ^a   García Arenzana, José M ^a   Esnal, Olatz ^b   Pérez Trallero, Emilio ^a,b,c  

^a HOSPITAL DONOSTIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Emm types; Erm(B) gene; Mef(A) gene; MLST; Mutation A2058G

Indexed keywords

AZITHROMYCIN; BACITRACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; NORFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CARRIER PROTEIN; MACROLIDE; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MUTATION; BACTERIUM ISOLATE; CHILD; CLONE; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; AGED; DRUG EFFECTS; GENETICS; GENOTYPE; HISTORY; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MUTATION; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; EUROPE; GENOTYPE; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84903880661     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku039     Document Type: Article

References (32)

1. Ralph AP, Carapetis JR. Group A streptococcal diseases and their global burden. Curr Top Microbiol Immunol 2013; 368: 1-27.
2. Grivea IN, Al-Lahham A, Katopodis GD et al. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother 2006; 50: 256-61.
3. Melo-Cristino J, Santos L, Silva-Costa C et al. The Viriato study: update on antimicrobial resistance of microbial pathogens responsible for community-acquired respiratory tract infections in Portugal. Paediatr Drugs 2010; 12 Suppl 1: 11-7.
4. Pérez-Trallero E, Montes M, Orden B et al. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007; 51: 1228-33.
5. Pérez-Trallero E, Urbieta M, Montes M et al. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25-31.
6. Wajima T, Murayama SY, Sunaoshi K et al. Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. J Med Microbiol 2008; 57: 1383-8.
7. Pérez-Trallero E, Martín-Herrero JE, Mazón A et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob Agents Chemother 2010; 54: 2953-9.
8. Bingen E, Bidet P, Mihaila-Amrouche L et al. Emergence of macrolideresistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 2004; 48: 3559-62.
9. Farmand S, Henneke P, Hufnagel M. Significant decline in the erythromycin resistance of group A Streptococcus isolates at a German paediatric tertiary care centre. Eur J Clin Microbiol Infect Dis 2012; 31: 707-10.
10. Van Heirstraeten L, Coenen S, Lammens C et al. Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium. Emerg Infect Dis 2012; 18: 1515-8.
11. Green MD, Beall B, Marcon MJ et al. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother 2006; 57: 1240-3.
12. Villaseñor-Sierra A, Katahira E, Jaramillo-Valdivia AN et al. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010. Int J Infect Dis 2012; 16: 178-81.
13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
14. Pérez-Trallero E, Garcia C, Orden B et al. Dissemination of emm28 erythromycin-, clindamycin-and bacitracin-resistant Streptococcus pyogenes in Spain. Eur J Clin Microbiol Infect Dis 2004; 23: 123-6.
15. Malbruny B, Nagai K, Coquemont M et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 2002; 49: 935-9.
16. Jalava J, Vaara M, Huovinen P. Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes. Ann Clin Microbiol Antimicrob 2004; 3: 5.
17. Yan SS, Fox ML, Holland SM et al. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob Agents Chemother 2000; 44: 3196-8.
18. Ardanuy C, Domenech A, Rolo D et al. Molecular characterization of macrolide-and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother 2010; 65: 634-43.
19. Silva-Costa C, Pinto FR, Ramirez M et al. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin Microbiol Infect 2008; 14: 1152-9.
20. d'Humières C, Cohen R, Levy C et al. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children. Int J Med Microbiol 2012; 302: 300-3.
21. Bergman M, Huikko S, Pihlajamäki M et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38: 1251-6.
22. Seppälä H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-6.
23. Malhotra-Kumar S, Lammens C, Chapelle S et al. Macrolide-and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis 2005; 11: 939-42.
24. Albertí S, García-Rey C, Domínguez MA et al. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J Clin Microbiol 2003; 41: 2385-90.
25. Willems RJ, Hanage WP, Bessen DE et al. Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 872-900.
26. Montes M, Tamayo E, Orden B et al. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain. Antimicrob Agents Chemother 2010; 54: 93-7.
27. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycinresistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-6.
28. Tait-Kamradt A, Davies T, Cronan M et al. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 2000; 44: 2118-25.
29. Chuang I, Van Beneden C, Beall B et al. Population-based surveillance for postpartum invasive group A Streptococcus infections, 1995-2000. Clin Infect Dis 2002; 35: 665-70.
30. Green NM, Zhang S, Porcella SF et al. Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 2005; 192: 760-70.
31. Silva-Costa C, Friães A, Ramirez M et al. Differences between macrolide resistant and susceptible Streptococcus pyogenes: the importance of clonal properties in addition to antibiotic consumption. Antimicrob Agents Chemother 2012; 56: 5661-6.
32. Creti R, Gherardi G, Imperi M et al. Association of group A streptococcal emm types with virulence traits and macrolideresistance genes is independent of the source of isolation. J Med Microbiol 2005; 54: 913-7.